TrialJournal for immunotherapy of cancer2024

Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders.

Brandon M Huffman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.